Skip to content

Research on the establishment and application of early lung cancer screening model based on cfDNA methylation markers

Research on the establishment and application of early lung cancer screening model based on cfDNA methylation markers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094031
Enrollment
Unknown
Registered
2024-12-16
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Group of patients with lung cancer who are eligible for clinical diagnosis:None

Sponsors

Xi'an Jiaotong University Second Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients aged 16-90 who meet the diagnostic criteria for lung cancer, and who have not undergone anti-tumor therapy such as surgery, radiotherapy, chemotherapy, etc.

Exclusion criteria

Exclusion criteria: Patients with other malignant tumors at the same time, who have received anti-tumor treatment such as surgery,radiotherapy, chemotherapy and so on treatment, severe chronic liver and kidney disease, severe autoimmune disease, the investigators believe that do not meet the requirements he who.

Design outcomes

Primary

MeasureTime frame
cfDNA methylation level in samples of lung cancer patients;

Secondary

MeasureTime frame
Levels of other biochemical or immunological markers of lung cancer patients;

Countries

China

Contacts

Public ContactZhu Huange

Xi'an Jiaotong University Second Affiliated Hospital

hgzhu2012@163.com+86 13310980443

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026